The severity of congenital hypothyroidism of central origin should not be underestimated.

CONTEXT Congenital hypothyroidism (CH) may be of thyroidal (CHT) or central origin (CHC). Worldwide, most neonatal screening programs are TSH-based and effectively detect CHT. Only a few screening programs measure total or free T4 and TSH simultaneously or stepwise, enabling detection of CHT as well as CHC. A frequently used argument against screening for CHC is its presumed mild hypothyroid character. In the recently published European Society for Paediatric Endocrinology (ESPE) CH consensus guidelines on screening, diagnosis, and management, severity of CH is classified based on initial free T4 (FT4) concentrations. OBJECTIVE Our objective was to assess disease severity of CHC compared with CHT in a Dutch cohort of CH patients. METHODS Pretreatment FT4 concentrations were analyzed in all children with CH detected by the Dutch neonatal T4+TSH+T4-binding-globulin (TBG) screening between 1995 and 2011. Disease severity was classified using the FT4-based ESPE classification. RESULTS Between 1995 and 2011, 1288 children were diagnosed with CH. Data of 1200 (143 CHC and 1057 CHT) were available for analysis. Based on FT4 concentrations, 4 children with CHC (2.8%) had severe, 75 (52.4%) moderate, and 64 (44.8%) mild CH. In the CHT group, 280 children (26.5%) had severe, 341 (32.3%) moderate, and 436 (41.2%) mild CH. CONCLUSION Our results indicate that, based on initial FT4 values, severe CH was much more prevalent in CHT compared with CHC. However, CHC itself should not be considered as only mild because more than half of CHC patients have moderate CH with initial FT4 below 10 pmol/L (0.78 ng/dl).

[1]  M. Polak,et al.  European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism , 2014, Hormone Research in Paediatrics.

[2]  F. Hirahara,et al.  Mass screening of newborns for congenital hypothyroidism of central origin by free thyroxine measurement of blood samples on filter paper. , 2012, European journal of endocrinology.

[3]  A. Grüters,et al.  Detection and treatment of congenital hypothyroidism , 2012, Nature Reviews Endocrinology.

[4]  H. Krude,et al.  Treating patients not numbers: the benefit and burden of lowering TSH newborn screening cut-offs , 2010, Archives of Disease in Childhood.

[5]  E. Eugster,et al.  Newborn screening results in children with central hypothyroidism. , 2010, The Journal of pediatrics.

[6]  S. Lafranchi Newborn screening strategies for congenital hypothyroidism: an update , 2010, Journal of Inherited Metabolic Disease.

[7]  K. Fujieda,et al.  Central Congenital Hypothyroidism Detected by Neonatal Screening in Sapporo, Japan (2000–2004): It’s Prevalence and Clinical Characteristics , 2008, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

[8]  J. Loeber,et al.  Clinical Effectiveness and Cost-Effectiveness of the Use of the Thyroxine/Thyroxine-Binding Globulin Ratio to Detect Congenital Hypothyroidism of Thyroidal and Central Origin in a Neonatal Screening Program , 2005, Pediatrics.

[9]  D. Fisher Next generation newborn screening for congenital hypothyroidism? , 2005, The Journal of clinical endocrinology and metabolism.

[10]  J. de Vijlder,et al.  Neonatal detection of congenital hypothyroidism of central origin. , 2005, The Journal of clinical endocrinology and metabolism.

[11]  M. Elmlinger,et al.  Reference Intervals from Birth to Adulthood for Serum Thyroxine (T4), Triiodothyronine (T3), free T3, free T4, Thyroxine Binding Globulin (TBG) and Thyrotropin (TSH) , 2001, Clinical chemistry and laboratory medicine.

[12]  L. Braverman,et al.  Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text , 1991 .